166
Participants
Start Date
June 30, 2004
Primary Completion Date
August 31, 2005
Tiotropium Bromide Inhalation Powder
Boehringer Ingelheim Investigational Site, Birmingham
Cooper Green Hospital, Birmingham
University of Alabama at Birmingham, Birmingham
David Geffen School of Medicine, Los Angeles
VA Greater Los angeles Health Care Systems, Sepulveda
Boehringer Ingelheim Investigational Site, Waterbury
Yale Univ. Pulmonary and Critical Care Medicine, West Haven
Emerald Coast Research Associates, Panama City
Bay Pines V. A. Medical Center, Saint Petersberg
Louisiana State University School of Medicine, New Orleans
LSU MC-Sheveport, Shreveport
Bronx VA Medical Center, The Bronx
Brody School of Medicine, East Carolina University, Greenville
Boehringer Ingelheim Investigational Site, Philadelphia
Temple University Hospital, Philadelphia
Boehringer Ingelheim Investigational Site, Charleston
Spartanburg Medical Research, Spartanburg
Attention: Amir Sharafkhaneh, M.D., Houston
VAMC Houston, Houston
Lead Sponsor
Boehringer Ingelheim
INDUSTRY